Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. In an ...
A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...
GENFIT signs royalty financing deal with HealthCare Royalty (HCRx) providing up to €185 million non-dilutive capital: €130 million upfront, ...
Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and ...
Kievit took the stand on Thursday and defence counsel Michael Klein began by asking him to explain a consent form he'd had the complainant sign. Kievit described the form as outlining various but rare ...